Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020
Summary The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space.The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions.
A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.
Scope - Global epidemiology metrics and trends
- Snapshot of epidemiological trends to date in the top three most-affected countries
- An overview of the pipeline for antivirals and vaccines
- Summary of available efficacy data
- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
- Highlights in deal-making trends, particularly public-private partnerships
- Spotlight on social media coverage
Reasons to Buy - Understand the global epidemiology of COVID-19
- Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
- Access an overview of the pipeline for therapeutics and vaccines
- Stay up to date on available efficacy data for pipeline-stage products
- View the clinical trials landscape by across key attributes
- Get up to speed on highlights in deal-making trends, particularly public-private partnerships
- Monitor top trends in social media coverage
Our reports have been used by over 10K customers, including:
Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease - Drugs in Development, 2021, provides an overview of the Non Alcoholic Fatty Liver Disease (Gastrointestinal)...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
Idiopathic Pulmonary Fibrosis - Opportunity Analysis and Forecasts to 2029 (Event Driven Update)
Idiopathic pulmonary fibrosis (IPF) is the most common subtype of idiopathic interstitial pneumonias (IIPs), which belong to a group of rare diseases termed interstitial lung diseases (ILDs).Idiopathic...
The global live cell imaging market size is projected to reach USD 2.8 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period. The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer,...
Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market.’’
The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period. The major factors driving the growth of...
Axial Spondyloarthritis: Forecast in Asia-Pacific Markets to 2028
The diagnosed prevalent cases of Axial Spondyloarthritis (AxSpA) are expected to increase from 6.1 million cases in 2018 to 8.0 million cases in 2028, at an annual growth rate (AGR) of 3.23% across the five growth markets...
Multiple Sclerosis: Dynamic Market Forecast to 2026 Summary Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the MS space,...
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hematopoietic stem cell. It is one of the rarest forms of leukemia in terms of annual incidence and accounts for 10 percent to 15 percent of all incident leukemia cases. However, it is anticipated to become the...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' GVK Biosciences...
Prescription Drug Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.